Market Capitalization (Millions $) |
10 |
Shares
Outstanding (Millions) |
7 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-49 |
Cash Flow (TTM) (Millions $) |
-11 |
Capital Exp. (TTM) (Millions $) |
0 |
Aptose Biosciences Inc
Aptose Biosciences Inc is a Canadian biotech company that specializes in the research and development of targeted therapies for cancer treatment. The company focuses on developing drugs that target specific molecular pathways involved in cancer growth and survival. Aptose Biosciences utilizes innovative technologies and collaborations with academic institutions and industry partners to discover and develop promising treatments. Their goal is to provide effective therapies that improve patient outcomes and address unmet medical needs in oncology.
Company Address: 251 Consumers Road, Suite 1105 Toronto 0 ON
Company Phone Number: 479-9828 Stock Exchange / Ticker: NASDAQ APTO
APTO is expected to report next financial results on March 22, 2024. |
|
|